R. Chopra, A. Goldstone, R. Pearce, T. Philip, F. Petersen et al., Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data., Journal of Clinical Oncology, vol.10, issue.11, pp.1690-1695, 1992.
DOI : 10.1200/JCO.1992.10.11.1690

L. Verdonck, A. Dekker, H. Lokhorst, E. Petersen, and H. Nieuwenhuis, Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma, Blood, vol.90, issue.10, pp.4201-4206, 1997.

S. Vigouroux, M. Michallet, R. Porcher, M. Attal, L. Ades et al., Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC), Haematologica, vol.92, issue.5, pp.627-661, 2007.
DOI : 10.3324/haematol.10924
URL : https://hal.archives-ouvertes.fr/inserm-00507510

E. Jabbour, C. Hosing, G. Ayers, R. Nunez, P. Anderlini et al., Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma, Cancer, vol.37, issue.12, pp.2481-2490, 2007.
DOI : 10.1002/cncr.22714

M. Brugiatelli, G. Bandini, G. Barosi, F. Lauria, V. Liso et al., Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation, Haematologica, vol.91, issue.12, pp.1662-73, 2006.

P. Dreger, P. Corradini, E. Kimby, M. Michallet, D. Milligan et al., Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus, Leukemia, vol.95, issue.1, pp.12-19, 2007.
DOI : 10.1200/JCO.2005.04.531

M. Kharfan-dabaja, C. Anasetti, and E. Santos, Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: An Evolving Concept, Biology of Blood and Marrow Transplantation, vol.13, issue.4, pp.373-85, 2007.
DOI : 10.1016/j.bbmt.2007.01.075

A. Sureda, S. Robinson, C. Canals, A. Carella, M. Boogaerts et al., Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, Journal of Clinical Oncology, vol.26, issue.3, pp.455-62, 2008.
DOI : 10.1200/JCO.2007.13.2415

M. Michallet, P. Dreger, L. Sutton, R. Brand, S. Richards et al., Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation, Blood, vol.117, issue.5, pp.1516-1537, 2011.
DOI : 10.1182/blood-2010-09-308775

J. Brown, H. Kim, A. P. Cutler, C. Fisher, D. Ho et al., Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome, Leukemia, vol.118, issue.2, pp.362-371, 2013.
DOI : 10.1200/JCO.2008.17.7279

A. Peniket, M. Ruiz-de-elvira, G. Taghipour, C. Cordonnier, E. Gluckman et al., An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation, Bone Marrow Transplantation, vol.31, issue.8, pp.31667-78, 2003.
DOI : 10.1038/sj.bmt.1703891

O. Ringdén, M. Labopin, F. Frassoni, G. Sanz, F. Demeocq et al., Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft, Bone Marrow Transplantation, vol.24, issue.4, pp.389-96, 1999.
DOI : 10.1038/sj.bmt.1701918

I. Aksentijevich, R. Jones, R. Ambinder, E. Garrett-mayer, and I. Flinn, Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed

I. Khouri, M. Keating, M. Körbling, D. Przepiorka, P. Anderlini et al., Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies., Journal of Clinical Oncology, vol.16, issue.8, pp.2817-2841, 1998.
DOI : 10.1200/JCO.1998.16.8.2817

E. Morris, K. Thomson, C. Craddock, P. Mahendra, D. Milligan et al., Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma, Blood, vol.104, issue.13, pp.3865-71, 2004.
DOI : 10.1182/blood-2004-03-1105

M. Sorror, M. Maris, B. Sandmaier, B. Storer, M. Stuart et al., Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia, Journal of Clinical Oncology, vol.23, issue.16, pp.3819-3848, 2005.
DOI : 10.1200/JCO.2005.04.569

I. Khouri, P. Mclaughlin, R. Saliba, C. Hosing, M. Korbling et al., Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab, Blood, vol.111, issue.12, pp.5530-5536, 2008.
DOI : 10.1182/blood-2008-01-136242

C. Tam, R. Bassett, C. Ledesma, M. Korbling, A. Alousi et al., Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma, Blood, vol.113, issue.18, pp.4144-52, 2009.
DOI : 10.1182/blood-2008-10-184200

I. Khouri, R. Bassett, N. Poindexter, O. Brien, S. Bueso-ramos et al., Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia, Cancer, vol.28, issue.20, pp.4679-88, 2011.
DOI : 10.1002/cncr.26091

K. Van-besien, F. Loberiza, . Jr, R. Bajorunaite, J. Armitage et al., Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma, Blood, vol.102, issue.10, pp.3521-3530, 2003.
DOI : 10.1182/blood-2003-04-1205

A. Sureda, C. Canals, R. Arranz, D. Caballero, J. Ribera et al., Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, Haematologica, vol.97, issue.2, pp.310-317, 2012.
DOI : 10.3324/haematol.2011.045757

S. Robinson, A. Goldstone, S. Mackinnon, A. Carella, N. Russell et al., Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation, Blood, vol.100, issue.13, pp.4310-4316, 2002.
DOI : 10.1182/blood-2001-11-0107

I. Khouri, R. Saliba, S. Giralt, M. Lee, G. Okoroji et al., Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, Blood, vol.98, issue.13, pp.3595-3604, 2001.
DOI : 10.1182/blood.V98.13.3595

K. Branson, R. Chopra, P. Kottaridis, G. Mcquaker, A. Parker et al., Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies, Journal of Clinical Oncology, vol.20, issue.19, pp.4022-4053, 2002.
DOI : 10.1200/JCO.2002.11.088

I. Khouri, M. Lee, R. Saliba, G. Jun, L. Fayad et al., Nonablative Allogeneic Stem-Cell Transplantation for Advanced/Recurrent Mantle-Cell Lymphoma, Journal of Clinical Oncology, vol.21, issue.23, pp.4407-4419, 2003.
DOI : 10.1200/JCO.2003.05.501

M. Escalón, R. Champlin, R. Saliba, S. Acholonu, C. Hosing et al., Nonmyeloablative Allogeneic Hematopoietic Transplantation: A Promising Salvage Therapy for Patients With Non-Hodgkin's Lymphoma Whose Disease Has Failed a Prior Autologous Transplantation, Journal of Clinical Oncology, vol.22, issue.12, pp.2419-2442, 2004.
DOI : 10.1200/JCO.2004.09.092

V. Rocha, M. Labopin, G. Sanz, W. Arcese, R. Schwerdtfeger et al., Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia, New England Journal of Medicine, vol.351, issue.22, pp.2276-85, 2004.
DOI : 10.1056/NEJMoa041469

M. Eapen, P. Rubinstein, M. Zhang, C. Stevens, J. Kurtzberg et al., Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study, The Lancet, vol.369, issue.9577, pp.1947-54, 2007.
DOI : 10.1016/S0140-6736(07)60915-5

E. Gluckman, V. Rocha, W. Arcese, G. Michel, G. Sanz et al., Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice, Experimental Hematology, vol.32, issue.4, pp.397-407, 2004.
DOI : 10.1016/j.exphem.2004.01.002

V. Rocha and E. Gluckman, Clinical Use of Umbilical Cord Blood Hematopoietic Stem Cells, Biology of Blood and Marrow Transplantation, vol.12, issue.1, pp.34-41, 2006.
DOI : 10.1016/j.bbmt.2005.09.006

M. Laughlin, M. Eapen, P. Rubinstein, J. Wagner, M. Zhang et al., Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia, New England Journal of Medicine, vol.351, issue.22, pp.2265-75, 2004.
DOI : 10.1056/NEJMoa041276

J. Barker, D. Weisdorf, T. Defor, B. Blazar, P. Mcglave et al., Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy, Blood, vol.105, issue.3, pp.1343-1350, 2005.
DOI : 10.1182/blood-2004-07-2717

K. Ballen, T. Spitzer, B. Yeap, S. Mcafee, B. Dey et al., Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in Adults, Biology of Blood and Marrow Transplantation, vol.13, issue.1, pp.82-91, 2007.
DOI : 10.1016/j.bbmt.2006.08.041

C. Rodrigues, G. Sanz, C. Brunstein, J. Sanz, J. Wagner et al., Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, Journal of Clinical Oncology, vol.27, issue.2, pp.256-63, 2009.
DOI : 10.1200/JCO.2007.15.8865

S. Giralt, E. Estey, M. Albitar, K. Van-besien, G. Rondón et al., Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy, Blood, vol.89, issue.12, pp.4531-4537, 1997.

S. Giralt, K. Ballen, D. Rizzo, A. Bacigalupo, M. Horowitz et al., Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research, Biology of Blood and Marrow Transplantation, vol.15, issue.3, pp.367-376, 2009.
DOI : 10.1016/j.bbmt.2008.12.497

A. Bacigalupo, K. Ballen, D. Rizzo, S. Giralt, H. Lazarus et al., Defining the Intensity of Conditioning Regimens: Working Definitions, Biology of Blood and Marrow Transplantation, vol.15, issue.12, pp.1628-1661, 2009.
DOI : 10.1016/j.bbmt.2009.07.004

K. Yuji, S. Miyakoshi, D. Kato, Y. Miura, T. Myojo et al., Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma, Biology of Blood and Marrow Transplantation, vol.11, issue.4, pp.314-322, 2005.
DOI : 10.1016/j.bbmt.2005.01.012

N. Majhail, D. Weisdorf, J. Wagner, T. Defor, C. Brunstein et al., Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma, Blood, vol.107, issue.9, pp.3804-3811, 2006.
DOI : 10.1182/blood-2005-09-3827

C. Brunstein, S. Cantero, Q. Cao, N. Majhail, B. Mcclune et al., Promising Progression-Free Survival for Patients Low and Intermediate Grade Lymphoid Malignancies after Nonmyeloablative Umbilical Cord Blood Transplantation, Biology of Blood and Marrow Transplantation, vol.15, issue.2, pp.214-236, 2009.
DOI : 10.1016/j.bbmt.2008.11.013

T. Gooley, J. Chien, S. Pergam, S. Hingorani, M. Sorror et al., Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation, New England Journal of Medicine, vol.363, issue.22, pp.2091-101, 2010.
DOI : 10.1056/NEJMoa1004383

R. Van-kampen, C. Canals, H. Schouten, A. Nagler, K. Thomson et al., Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry, Journal of Clinical Oncology, vol.29, issue.10, pp.1342-1350, 2011.
DOI : 10.1200/JCO.2010.30.2596

C. Brunstein, M. Eapen, K. Ahn, F. Appelbaum, K. Ballen et al., Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes, Blood, vol.119, issue.23, pp.5591-5599, 2012.
DOI : 10.1182/blood-2011-12-400630

M. Eapen, V. Rocha, G. Sanz, A. Scaradavou, M. Zhang et al., Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis, The Lancet Oncology, vol.11, issue.7, pp.653-60, 2010.
DOI : 10.1016/S1470-2045(10)70127-3

C. Brunstein, J. Gutman, D. Weisdorf, A. Woolfrey, T. Defor et al., Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood, Blood, vol.116, issue.22, pp.4693-4702, 2010.
DOI : 10.1182/blood-2010-05-285304